Valvuloplasty stands as a pivotal medical intervention dedicated to addressing valvular heart disease, a condition marked by the impairment or constriction of heart valves. In this sophisticated procedure, a specialized catheter, housing a deflated balloon, navigates through the intricate network of blood vessels until it reaches the targeted heart valve in need of correction. With precision and care, the balloon is then inflated, strategically widening the narrowed valve. This meticulous approach facilitates improved blood circulation, mitigating symptoms associated with valvular disorders and promoting overall cardiovascular health. Distinguished by its minimally invasive nature, valvuloplasty presents a compelling alternative to the conventional realm of open-heart surgery. This innovation translates to shorter recovery periods and diminished postoperative discomfort for patients undergoing the procedure. As medical advancements continue to propel the field forward, valvuloplasty emerges as a beacon of hope for individuals grappling with valvular heart disease, offering a less invasive avenue for restoring cardiac function and enhancing the quality of life.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom